Tseng, Hubert
Gage, Jacob A.
Shen, Tsaiwei
Haisler, William L.
Neeley, Shane K.
Shiao, Sue
Chen, Jianbo
Desai, Pujan K.
Liao, Angela
Hebel, Chris
Raphael, Robert M.
Becker, Jeanne L.
Souza, Glauco R.
Article History
Received: 9 April 2015
Accepted: 12 August 2015
First Online: 14 September 2015
Change Date: 5 October 2015
Change Type: Update
Change Details: The version of this Article previously published included an incorrect version of Supplementary Movie 1. The correct Supplementary Movie 1 now accompanies this Article.
Competing interests
: The University of Texas M. D. Anderson Cancer Center (UTMDACC) and Rice University, along with their researchers, have filed patents on the technology and intellectual property reported here. If licensing or commercialization occurs, the researchers are entitled to standard royalties. G.R.S and R.M.R. have equity in Nano3D Biosciences, Inc. H.T. and J.A.G. have stock options in Nano3D Biosciences, Inc. UTMDACC and Rice University manage the terms of these arrangements in accordance to their established institutional conflict-of-interest policies.